← Oncology Approval Tracker

FDA DECISION ·

Enzalutamide (generic Xtandi)

enzalutamide · Actavis Laboratories

First generic approvalFirst genericProstate cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

First generic 40 mg enzalutamide capsules for castration-resistant prostate cancer.

LAMPGEN ANALYSIS

Why it matters

The first generic action applies to a capsule strength and a defined prostate cancer setting.

What research teams should watch

Record capsule strength and formulation and distinguish castration-resistant disease from other label populations.

PRIMARY RECORDS

Sources